On September 8, 2023, Edward Jordan informed Humanigen, Inc. of his resignation from his position as Chief Commercial Officer of the Company, effective September 14, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -97.01% | +19,900.00% | -83.33% |
Apr. 12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
Mar. 08 | Final DIP Financing Approved for Humanigen, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-83.33% | 23.82K | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- HGENQ Stock
- News Humanigen, Inc.
- Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer